Clinical Trial Supply and Logistics Global Market Report 2024

The clinical trial supply and logistics market size has grown strongly in recent years. It will grow from $4.31 billion in 2023 to $4.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The increase in the historical period can be ascribed to the rise in the prevalence of chronic diseases, globalization of clinical trials, increased demand for novel therapies, a surge in the number of clinical trials, and advancements in healthcare infrastructure.

The clinical trial supply and logistics market size is expected to see strong growth in the next few years. It will grow to $6.52 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The anticipated growth in the forecast period can be attributed to a rising demand for personalized medicine, an increasing number of clinical trials, a growing prevalence of chronic diseases, a heightened focus on patient-centric trials, and the growing utilization of virtual trials. Noteworthy trends expected in the forecast period encompass strategic collaborations between clinical trial supply and logistics companies, pharmaceutical entities, and other stakeholders, a rise in the outsourcing of clinical trial services, ongoing technological advancements, an increase in research and development expenditure, and the enforcement of stringent regulatory compliance and quality assurance in clinical trial supply.

The anticipated growth in the clinical trial supply and logistics market is expected to be propelled by the increasing number of clinical trials. These trials are research studies involving human participants to assess the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Clinical trial supply and logistics play a pivotal role in delivering essential materials, including the collection and transportation of biological specimens, investigational drugs and kits, expertise for permit applications, customs clearance, and other necessary components to ensure the smooth execution of clinical trials. For instance, as of July 2023, ClinicalTrials.gov, a registry of clinical trials by the United States National Library of Medicine, reported an increase in registered clinical studies from 399,499 in 2022 to 437,533 by July 2023, spanning all 50 states in the United States and 221 countries. Of these, 141,513 studies (31% of the total) were registered in the U.S., while 244,707 studies (53% of the total) were registered in non-U.S. locations. Therefore, the growing number of clinical trials is a driving force behind the expansion of the clinical trial supply and logistics market.

The surge in research and development (R&D) expenditures is expected to contribute to the growth of the clinical trial supply and logistics market. R&D expenditures represent the financial resources allocated by organizations for research and development activities aimed at innovation and the creation of new products or services. The clinical trial supply and logistics market play a vital role in supporting increased R&D expenditure by efficiently managing and distributing investigational drugs, ensuring the seamless execution of clinical trials, and expediting research and development processes. For example, in January 2023, The National Center for Science and Engineering Statistics (NCSES) reported a substantial increase in U.S. research and development expenditures, reaching $717 billion in 2020 and an estimated increase to $792 billion in 2021. The majority of these expenditures, totaling $471.7 billion, was allocated to experimental development, constituting 66% of the total R&D spending. Hence, the escalating R&D expenditures are a driving factor for the growth of the clinical trial supply and logistics market.


The adoption of technology stands out as a prominent trend gaining traction in the clinical trial supply and logistics market. Major companies within this sector are embracing new technologies to maintain and strengthen their positions. For example, in May 2021, N-SIDE, a Belgium-based advanced analytics software consulting company, introduced the N-SIDE Production App. This innovative application is designed to assist biopharma companies in addressing challenges and risks related to manufacturing trial material. Leveraging a powerful optimization algorithm, the Production App facilitates critical decision-making in the clinical supply chain, including choices related to lot sizing, stability plans, network management, scale-up strategy, and lot-to-lot allocation. The app plays a crucial role in minimizing waste, reducing costs and timelines, and ensuring timely communication of any changes to all stakeholders.

Major players in the clinical trial supply and logistics market are placing a strategic focus on product launches, such as the introduction of electronic data capture platforms, to reshape the landscape of clinical research. An electronic data capture platform is a digital system that efficiently collects, manages, and stores clinical trial data in electronic format, enhancing the accuracy, security, and speed of the data capture process. For instance, in March 2023, Cloudbyz, a leading provider of unified clinical trial management solutions based in the U.S., unveiled EDC 2.0, a groundbreaking platform. Distinguished by features such as a user-friendly interface, advanced data security, intelligent data validation, real-time monitoring, analytics, and compliance with international regulatory standards, this product launch is highly significant in streamlining data management processes, reducing errors, and expediting regulatory approvals, ultimately enhancing efficiency in research endeavors.

In October 2022, Myonex, a clinical trial supply company based in the U.S., acquired the clinical trial supply and drug wholesale businesses from Hubertus Apotheke for an undisclosed amount. This strategic acquisition is anticipated to bolster Myonex's presence throughout the European Union in the field of clinical trial supply. Hubertus Apotheke, headquartered in Germany, is a provider of a diverse range of pharmaceuticals and medical devices.

Major companies operating in the clinical trial supply and logistics market report are United Parcel Service, DHL Group, FedEx Corporation, Thermo Fisher Scientific Inc., IQVIA, ICON plc, Eurofins Scientific, Catalent Inc., Intertek Group plc, Parexel International Corporation, UDG Healthcare PLC., Almac Group, World Courier, Piramal Pharma Solutions, Sharp Clinical Services Ltd., Clinigen Group, PCI Pharma Services, Movianto Group, Cold Chain Technologies, Biocair International Limited, QuickSTAT, Wasdell Group, Klifo A/S, TrakCel, Packaging Coordinators Inc., Biotec Services International Limited, Proventa International, Inceptua Group.

North America was the largest region in the clinical trial supply and logistics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial supply and logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical trial supply and logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary services provided in clinical trial supply and logistics encompass logistics and distribution, storage and retention, packaging labeling and blinding, manufacturing, comparator sourcing, and others. Logistics involves the strategic planning of moving commodities, while distribution executes the conveyance of these goods through careful planning. The different clinical trial phases include phase I, phase II, phase III, and phase IV, covering various areas such as oncology, cardiovascular diseases, respiratory diseases, CNS (central nervous system) and mental disorders, among others. These services are utilized by diverse end-users, including pharmaceuticals, biologicals, and medical devices.

The clinical trial supply and logistics market research report is one of a series of new reports that provides clinical trial supply and logistics market statistics, including clinical trial supply and logistics industry global market size, regional shares, competitors with a clinical trial supply and logistics market share, detailed clinical trial supply and logistics market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial supply and logistics industry. This clinical trial supply and logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical trial supply and logistics market includes revenues earned by entities by providing services such as clinical supply planning, import and export compliance, inventory management, packaging services, and real-time track and trace and delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.